Experimental models of Behçet's disease

Drug Discovery Today: Disease Models

Volumn 3, Issue 1, 2006, Pages 11-14

  Baharav, Ehud ^a   Weinberger, Abraham ^a   Mor, Felix ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPHENOTANE; FENITROTHION; HEAT SHOCK PROTEIN; HLA B51 ANTIGEN; ORGANOCHLORINE DERIVATIVE; ORGANOPHOSPHATE; POLYCHLORINATED BIPHENYL; TROPOMYOSIN;

AUTOIMMUNITY; BACTERIAL INFECTION; BEHCET DISEASE; DISEASE MODEL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EXPERIMENTAL MODEL; GENETIC MARKER; GEOGRAPHIC DISTRIBUTION; HEREDITY; HERPES SIMPLEX VIRUS; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; STREPTOCOCCUS; VIRUS INFECTION;

EID: 33646491019     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2006.03.008     Document Type: Review

References (16)

1. Sakane T., et al. Behcet's disease. N. Engl. J. Med. 341 (1999) 1284-1291
2. Hegab S., and Al-Mutawa S. Immunopathogenesis of Behcet's disease. Clin. Immunol. 96 (2000) 174-186
3. Direskeneli H. Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann. Rheum. Dis. 60 (2001) 996-1002
4. Hori Y., et al. Experimental Behcet's disease and ultrastructural X-ray microanalysis of pathological tissues. J. Dermatol. 6 (1979) 31-37
5. Bang D., et al. Electron microscopic observation on dark endothelial cells in erythema nodosum-like lesions of Behcet's disease with ultrastructural X-ray spectroanalysis. J. Toxicol. Sci. 12 (1987) 321-328
6. Kaneko F., et al. Streptococcal infection in the pathogenesis of Behcet's disease and clinical effects of minocycline on the disease symptoms. Yonsei Med. J. 38 (1997) 444-454
7. Hu W., et al. Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur. J. Immunol. 28 (1998) 2444-2455
8. Smith D.W., and Nagler-Anderson C. Preventing intolerance: the induction of nonresponsiveness to dietary and microbial antigens in the intestinal mucosa. J. Immunol. 174 (2005) 3851-3857
9. Sohn S., et al. Behcet's disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur. J. Dermatol. 8 (1998) 21-23
10. Saenz A., et al. Pharmacotherapy for Behcet's syndrome. Cochrane Database Syst. Rev. (2000) CD001084
11. de Smet M.D., et al. Human S-antigen determinant recognition in uveitis. Invest. Ophthalmol. Vis. Sci. 42 (2001) 3233-3238
12. Kurhan-Yavuz S., et al. Anti-MHC autoimmunity in Behcet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis. Clin. Exp. Immunol. 120 (2000) 162-166
13. Mor F., et al. Identification of alpha-tropomyosin as a target self-antigen in Behcet's syndrome. Eur. J. Immunol. 32 (2002) 356-365
14. Mahesh S.P., et al. Alpha tropomyosin as a self-antigen in patients with Behcet's disease. Clin. Exp. Immunol. 140 (2005) 368-375
15. Baharav E., et al. Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J. Nutr. 134 (2004) 1964-1969
16. Takeno M., et al. Excessive function of peripheral blood neutrophils from patients with Behcet's disease and from HLA-B51 transgenic mice. Arthritis Rheum. 38 (1995) 426-433